Hostalek U - Search Results

1

Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study.

Pinon A, Allignol A, Hohenberger T, Foch C, Boutmy E, Hostalek U. Pinon A, et al. Among authors: hostalek u. J Comp Eff Res. 2024 Nov;13(11):e230027. doi: 10.57264/cer-2023-0027. Epub 2024 Nov 17. J Comp Eff Res. 2024. PMID: 39417364 Free PMC article.

2

Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.

Foch C, Allignol A, Hostalek U, Boutmy E, Hohenberger T. Foch C, et al. Among authors: hostalek u. Int J Clin Pract. 2022 Jul 30;2022:6124559. doi: 10.1155/2022/6124559. eCollection 2022. Int J Clin Pract. 2022. PMID: 35989866 Free PMC article. Review.

3

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink.

Foch C, Allignol A, Hohenberger T, Boutmy E, Schaefer S, Hostalek U. Foch C, et al. Among authors: hostalek u. J Comp Eff Res. 2022 Apr;11(6):423-436. doi: 10.2217/cer-2021-0305. Epub 2022 Feb 22. J Comp Eff Res. 2022. PMID: 35189710 Free article.

4

Metformin for diabetes prevention: update of the evidence base.

Hostalek U, Campbell I. Hostalek U, et al. Curr Med Res Opin. 2021 Oct;37(10):1705-1717. doi: 10.1080/03007995.2021.1955667. Epub 2021 Jul 28. Curr Med Res Opin. 2021. PMID: 34281467 Review.

5

Observational study of the efficacy of prolonged-release metformin in people with prediabetes.

Hostalek U, Zilahi Z. Hostalek U, et al. Curr Med Res Opin. 2020 Mar;36(3):397-401. doi: 10.1080/03007995.2019.1700360. Epub 2019 Dec 14. Curr Med Res Opin. 2020. PMID: 31793818

6

The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations.

Gebregergish SB, Hashim M, Heeg B, Wilke T, Rauland M, Hostalek U. Gebregergish SB, et al. Among authors: hostalek u. Expert Rev Pharmacoecon Outcomes Res. 2020 Apr;20(2):207-219. doi: 10.1080/14737167.2020.1688146. Epub 2019 Nov 11. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31674846

7

Global epidemiology of prediabetes - present and future perspectives.

Hostalek U. Hostalek U. Clin Diabetes Endocrinol. 2019 May 9;5:5. doi: 10.1186/s40842-019-0080-0. eCollection 2019. Clin Diabetes Endocrinol. 2019. PMID: 31086677 Free PMC article.

8

Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review.

Razvi S, Hostalek U. Razvi S, et al. Among authors: hostalek u. Curr Med Res Opin. 2019 Jul;35(7):1215-1220. doi: 10.1080/03007995.2019.1570769. Epub 2019 Jan 25. Curr Med Res Opin. 2019. PMID: 30648440 Review.

9

Prediabetes management in the Middle East, Africa and Russia: Current status and call for action.

Assaad Khalil SH, Abdelaziz SI, Al Shammary A, Al Zahrani A, Amir A, Elkafrawy N, Hassoun AA, Hostalek U, Jahed A, Jarrah N, Mrabeti S, Paruk I, Zilov AV. Assaad Khalil SH, et al. Among authors: hostalek u. Diab Vasc Dis Res. 2019 May;16(3):213-226. doi: 10.1177/1479164118819665. Epub 2019 Jan 3. Diab Vasc Dis Res. 2019. PMID: 30606039 Free article. Review.

10

A new formulation of levothyroxine engineered to meet new specification standards.

Lipp HP, Hostalek U. Lipp HP, et al. Among authors: hostalek u. Curr Med Res Opin. 2019 Jan;35(1):147-150. doi: 10.1080/03007995.2018.1545635. Epub 2018 Nov 26. Curr Med Res Opin. 2019. PMID: 30406687 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters